Clinical TrialsSearch results
Number of results: 2568
Recruiting
- A Phase I clinical study of KK2260 in patients with advanced or metastatic solid tumors
- Advanced or metastatic solid tumors, esophageal cancer, head and neck squamous cell carcinoma
- Takase Riho
- 2023-09-27
Recruiting
- A Phase I Clinical Study of NS-025 in Healthy Subjects
- Healthy volunteer
- Higashioka Masaya
- 2022-11-29
Other
- A Phase I Dose Intensification Study of three dimentional conformal thoracic radiotherapy with concurrent cisplatin and TS-1 for unresectable stage III non-small cell lung cancer
- non-small cell lung cancer
- Shizuoka Cancer Center, The Cancer Institute Hospital of JFCR
- 2008-12-02
Other
- A Phase I study of cabozantinib monotherapy in pediatric patients with recurrent and/or refractory solid tumors
- Refractory pediatric solid tumor
- Arakawa Ayumu
- 2022-02-15
Other
- A phase I study of cancer vaccine with NY-ESO-1 overlapping peptides in patients with advanced cancers expressing NY-ESO-1 antigen
- advanced esophageal cancer, stomach cancer, non-small cell lung cancer (NSCLC), malignant melanoma, bladder cancer.
- Department of Immunology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- 2009-04-10
Recruiting
- A PHASE I STUDY OF ERY974 IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
- LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA
- Wataya Takafumi
- 2021-03-01
Recruiting
- A phase I study of KDH-136
- Individuals with pulpal necrosis (initial treatment) or those who have undergone pulpectomy.
- Mitsumasa Nakamura
- 2024-03-12
Recruiting
- A Phase I Study of NS-917 in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Acute Myeloid Leukemia
- Higashioka Masaya
- 2021-11-26
Other
- A PHASE I STUDY OF PRALSETINIB IN PATIENTS WITH RET ALTERED SOLID TUMOR
- RET altered solid tumor
- Yanagitani Noriko
- 2021-06-11
Recruiting
- A phase I study of ROSE12 alone and in combination with other anti-tumor agents in patients with solid tumors
- solid tumor
- Ajari Ifode
- 2023-05-15